0.0050
+0.0030
+(150.00%)
As of April 11 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
Total Revenue
376.7950
Cost of Revenue
559.5560
Gross Profit
-182.7600
Operating Expense
1,979.1040
Operating Income
-2,161.8650
Net Non Operating Interest Income Expense
-369.0310
Other Income Expense
165.2360
Pretax Income
-2,381.4470
Tax Provision
135.7430
Net Income Common Stockholders
-2,517.1910
Diluted NI Available to Com Stockholders
-2,517.1910
Basic EPS
-98.66
Diluted EPS
-98.66
Basic Average Shares
28.1600
Diluted Average Shares
28.1600
Total Operating Income as Reported
-2,177.6530
Total Expenses
2,538.6600
Net Income from Continuing & Discontinued Operation
-2,517.1910
Normalized Income
-2,624.5944
Interest Expense
374.9770
Net Interest Income
-369.0310
EBIT
-2,006.4700
EBITDA
-1,559.8610
Reconciled Cost of Revenue
559.5560
Reconciled Depreciation
446.6090
Net Income from Continuing Operation Net Minority Interest
-2,517.1910
Total Unusual Items Excluding Goodwill
165.2360
Total Unusual Items
165.2360
Normalized EBITDA
-1,725.0970
Tax Rate for Calcs
0.0004
Tax Effect of Unusual Items
57.8326
9/24/57255 - 6/17/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARCH.V Arch Biopartners Inc.
1.8500
-2.12%
IMM.AX Immutep Limited
0.2450
+2.08%
PHRM.CN PharmaTher Holdings Ltd.
0.2000
-4.76%
TRVN Trevena, Inc.
1.1300
+2.73%
MIRM Mirum Pharmaceuticals, Inc.
39.27
-0.78%
IMMP Immutep Limited
1.5110
+3.49%
CYBN.NE Cybin Inc.
10.30
+10.28%
PSTV Plus Therapeutics, Inc.
0.6210
-17.15%
OCEA Ocean Biomedical, Inc.
0.0441
+1.38%
CRMD CorMedix Inc.
6.91
0.00%